A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to learn if BMS-512148, added to insulin and
one or two anti-diabetes medications (metformin and/or pioglitazone or rosiglitazone), can
help reduce the blood sugar levels compared to insulin and one or two anti-diabetes
medications (metformin and/or pioglitazone or rosiglitazone) alone, in subjects with type 2
diabetes. The safety of this treatment will also be studied.